$24.36
0.53[2.22%]
At close: Apr 26
$24.36
0[0.00%]
After Hours: 4:20PM EDT
Avidity Biosciences
(NASDAQ:RNA)Avidity Biosciences Stock (NASDAQ:RNA), Insider Trading Activity
Avidity Biosciences: Insider buying and selling updated today.
Insider Shares Owned
286.679K
Insider Percentage Owned
0.36%
Institutional Shares Held
46.247M
Institutional Percentage Held
58.0%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22, 2024 | ARTHUR LEVIN | DIRECTOR | 0 | $12.03 | -$107.92K | SELL-OPTIONS | 0.00% | 268.702K | Apr 19 | View |
| Apr 03, 2024 | ARTHUR LEVIN | DIRECTOR | -20K | $27.11 | -$542.21K | SELL | -6.93% | 268.702K | Apr 03 | View |
| Apr 03, 2024 | Sarah Boyce | PRESIDENT AND CEO | 0 | $13.74 | -$700.20K | SELL-OPTIONS | 0.00% | 112.117K | Apr 02 | View |
| Mar 21, 2024 | ARTHUR LEVIN | DIRECTOR | 0 | $12.60 | -$113.65K | SELL-OPTIONS | 0.00% | 288.702K | Mar 19 | View |
| Mar 15, 2024 | Michael MacLean | CHIEF FINANCIAL OFFICER | 0 | $16.67 | -$627.96K | SELL-OPTIONS | 0.00% | 44.093K | Mar 13 | View |
| Mar 12, 2024 | ARTHUR LEVIN | DIRECTOR | -2.641K | $11.64 | -$578.02K | SELL | -0.91% | 288.702K | Mar 12 | View |
| Mar 12, 2024 | Sarah Boyce | PRESIDENT AND CEO | 0 | $11.47 | -$2.29M | SELL-OPTIONS | 0.00% | 112.117K | Mar 08 - Mar 12 | View |
| Mar 05, 2024 | Sarah Boyce | PRESIDENT AND CEO | 0 | $10.69 | -$1.59M | SELL-OPTIONS | 0.00% | 112.117K | Mar 01 | View |
| Jan 23, 2024 | ARTHUR LEVIN | DIRECTOR | -1.859K | $10.13 | -$18.83K | SELL | -0.63% | 291.343K | Jan 22 | View |
| Jan 23, 2024 | Sarah Boyce | PRESIDENT AND CEO | 57.408K | $10.13 | -$51.58K | GRANT | ∞ | 44.008K | Jan 20 - Jan 22 | View |
| Jan 23, 2024 | Michael Flanagan | CSTO | 15.871K | $10.13 | -$41.83K | GRANT | 79.36% | 35.871K | Jan 20 - Jan 22 | View |
| Jan 23, 2024 | Teresa McCarthy | CHIEF HUMAN RESOURCES OFFICER | 14.435K | $10.13 | -$20.92K | GRANT | 555.19% | 17.035K | Jan 20 - Jan 22 | View |
| Jan 23, 2024 | Michael MacLean | CHIEF FINANCIAL OFFICER | 20.884K | $10.13 | -$16.37K | GRANT | ∞ | 16.884K | Jan 20 - Jan 22 | View |
| Mar 17, 2023 | ARTHUR LEVIN | DIRECTOR | 0 | $11.63 | -$2.08K | SELL-OPTIONS | 0.00% | 293.202K | Mar 15 | View |
| Feb 15, 2023 | ARTHUR LEVIN | CHIEF SCIENTIFIC OFFICER | 0 | $12.45 | -$224.17K | SELL-OPTIONS | 0.00% | 293.202K | Feb 14 | View |
| Feb 03, 2023 | Sarah Boyce | PRESIDENT AND CEO | 0 | $12.80 | -$1.16M | SELL-OPTIONS | 0.00% | 53.352K | Feb 01 - Feb 03 | View |
| Jan 17, 2023 | ARTHUR LEVIN | CHIEF SCIENTIFIC OFFICER | 0 | $11.62 | -$207.63K | SELL-OPTIONS | 0.00% | 275.202K | Jan 12 | View |
| Jan 03, 2023 | ARTHUR LEVIN | CHIEF SCIENTIFIC OFFICER | 0 | $11.63 | -$830.97K | SELL-OPTIONS | 0.00% | 1.33K | Dec 29 | View |
| Aug 31, 2022 | ARTHUR LEVIN | CHIEF SCIENTIFIC OFFICER | 0 | $11.48 | -$1.70M | SELL-OPTIONS | 0.00% | 275.202K | Aug 12 - Aug 16 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.